| 00:00 | Symposium: Lessons Learned about COVID-19 |
| 105.4 |
Immunogenetics (HLA and ABO) Lori Jeanne West, Canada |
| 105.6 |
Global Impact of COVID-19 on Transplantation Alexandre Loupy, France |
| 105.1 |
Virology, Epidemiology and Clinical Course Olivia S. Kates, United States |
| 105.2 |
Organ Specific Involvement of COVID-19 Aneesha Anand Shetty, United States |
| 105.3 |
Diagnostics: PCR, Antigen Detection and Serology Robin Patel, United States |
| 105.5 |
Therapeutics & Vaccines Michael G. Ison, United States |
| 00:00 | Symposium: Transplanting in the Era of COVID-19 |
| 110.2 |
When a Recipient with COVID-19 Can Proceed to Transplant Paolo Antonio Grossi, Italy |
| 110.1 |
Donor Screening and the Risk of Virus Transmission Thomas D. Mone, United States |
| 110.4 |
Transplantation in the Hot Zone Jean C. Emond, United States |
| 110.3 |
Lung Transplantation for COVID-19 Jingyu Chen, People's Republic of China |
| 110.5 |
Transplantation and Ethical Issues in the COVID Era: Doing the right thing depends on location, resources and disease burden Peter G. Stock, United States |
| 00:15 - 02:00 | State-of-the-Art Session: Expanding the Donor Pool, Pushing the Limits |
| 222.2 |
Use of DCD organs in heart and lung transplant Gregory I Snell, Australia |
| 222.1 |
Use of HCV positive organs into HCV negative recipients David Goldberg, United States |
| 222.3 |
Transplant outcomes from older donors > Age 60 Colleen L. Jay, United States |
| 07:30 - 08:15 | Oral Abstracts Session: Kidney Transplantation: Underlying diseases and infections |
| 250.1 |
Cryptococcoma due to Cryptococcus albidus of a transplant kidney in a patient presenting with recurrent urinary tract infection: A clinical and metagenome sequencing study Ziyan Yan, People's Republic of China |
| 250.4 |
H1N1: A forgotten and mysterious entity in post renal transplant patients Sanshriti Chauhan, India |
| 250.3 |
DEEPGRAFT, a deep learning algorithm to classify kidney transplant diseases from digital whole slide biopsy images Jesper Kers, Netherlands |
| 250.2 |
Relationship between circulatory T follicular helper cells and CMV infection in kidney transplant recipients Patricia Suàrez-Fernández, Spain |
| 08:15 - 10:00 | State-of-the-Art Session: Managing Immunosuppression When Things Go Wrong |
| 261.1 |
Managing IS in recipients with a failing graft Sangho Lee, Korea |
| 261.3 |
Managing IS in recipients treated for malignancies Daniel Seron, Spain |
| 261.2 |
Managing IS in recipients with complex infections Peter Chin-Hong, United States |
| 15:15 - 17:00 | State-of-the-Art Session: Social Media for Scientists |
| 291.3 |
Impact of social media on research dissemination Carla C. Baan, Netherlands |
| 291.1 |
Introduction and creating networks Frank JMF Dor, United Kingdom |
| 291.2 |
Healthcare and patient education Macey L. Henderson, United States |
| 22:00 - 23:30 | Workshop Session: What the ID Doc should know about … |
| 302.4 |
Rejection in intestinal transplant Gabriel E. Gondolesi, Argentina |
| 302.1 |
CLAD Gregory I Snell, Australia |
| 302.2 |
Bilomas Prema Raj Jeyaraj, Singapore |
| 302.3 |
Delayed allograft function after renal transplant Roslyn B Mannon, United States |
| 00:15 - 02:00 | Workshop Session: Sex in the Time of SARS-CoV-2 – Relevance to transplantation |
| 323.1 |
Sex, gender, and their impact on COVID 19 Deborah Clegg, United States |
| 323.2 |
Sex mAtteRS-CoV-2 in Transplantation Ruth Sapir-Pichhadze, Canada |
| 323.3 |
Panelists Bethany J. Foster, Canada |
| Biff F. Palmer, United States |
| Amanda Vinson, Canada |
| 07:30 - 08:15 | Oral Abstracts Session: Infectious Diseases |
| 353.2 |
A recent diagnosis of tuberculosis is a risk factor for post-transplant morbidity & mortality after liver transplantation: A propensity score match-based analysis Pradez Sapkota, India |
| 353.3 |
Pneumocystis pneumonia occurrence and prophylaxis duration in kidney transplant recipients according to perioperative treatment with rituximab Hyunwook Kwon, Korea |
| 353.4 |
Gram negative blood stream infection in renal transplant recipients: Risk factors and outcome from a transplant center in Pakistan Sunil Kumar Dodani, Pakistan |
| 353.5 (P-9.02 in Journal) |
Impact of non-active hepatitis B on patient survival after renal transplantation Marcel RG Naik, Germany |
| 15:15 - 17:00 | State-of-the-Art Session: How Sex Impacts Post-Transplant Course |
| 392.2 |
Sex differences in infection risks and vaccine responses Deepali Kumar, Canada |
| 392.1 |
Sex differences in cancer risk post-transplant Anna Buxeda, Spain |
| 392.3 |
Sex and the heart: Major cardiovascular events in transplantation Darshana Dadhania, United States |
| 23:30 - 00:15 | Oral Abstracts Session: Kidney Transplantation: Novel approaches to monitoring |
| 410.1 (P-11.189 in the Journal) |
Reactivation of murine polyomavirus replication by renal ischemia-reperfusion injury and immunosuppression Gang Huang, People's Republic of China |
| 410.3 |
Analysis of the difference of the monitoring results of TCR high variable area in renal transplant recipients after treatment with different immune induction schemes Tian Puxun, People's Republic of China |
| 410.4 |
Novel human kidney cell subsets identified by Mux-Seq Tara Sigdel, United States |
| 00:15 - 02:00 | State-of-the-Art Session: Preventable Infections - An Ounce of Prevention... |
| 420.2 |
Screening and decolonization of MDROs pre-transplant: Is there a role? Stephanie Pouch, United States |
| 420.1 |
Respiratory viruses - Impact on our recipients Michael G. Ison, United States |
| 420.3 |
Keeping the fungi out of the transplant ward Monica Slavin, Australia |
| 00:15 - 02:00 | State-of-the-Art Session: Challenges for Solid Organ Tx in the Developing World |
| 421.1 |
What should be our focus to improve equity and access to transplant "all organs" in middle income countries? Liliana Bisigniano, Argentina |
| 421.2 |
Which diseases are unique in middle income countries, and what should we learn to avoid transmission when a transplant recipient fly abroad? Camille Nelson Kotton, United States |
| 13:00 - 14:30 | Workshop Session: CMV - What's New |
| 477.3 |
New risks for CMV in solid organ and stem cell transplant recipients José Maria Aguado, Spain |
| 477.1 |
New drugs against an old foe Francisco M Marty, United States |
| 477.2 |
Immune monitoring Camille Nelson Kotton, United States |
| 14:30 - 15:15 | Oral Abstracts Session: Donation Issues |
| 481.4 |
Evaluation of the mechanism of action of hepatic hypothermic oxygenated machine perfusion (HOPE) using microdialysis in a clinical setting Damiano Patrono, Italy |
| 481.1 |
Consent to organ offers from public health service “increased risk” donors decreases time to transplant and waitlist mortality Yvonne Kelly, United States |
| 481.2 |
Executive order on advancing american kidney health: A Markov analysis of long-term costs Rashikh A Choudhury, United States |
| 481.3 |
Outcomes of non-liver solid organ transplantation using hepatitis C positive donors to hepatitis C negative recipients: A multicenter experience Kristen L Ryland, United States |
| 15:15 - 17:00 | State-of-the-Art Session: Paediatric Transplantation Around the World |
| 491.1 |
Paediatric kidney transplantation around the world Mignon McCulloch, South Africa |
| 491.2 |
Cost Effective Immunosuppressive Medications Around the World Katherine Twombley, United States |
| 491.3 |
Variety of vaccine preventive paediatric infectious diseases around the world Lara Danziger-Isakov, United States |
| 18:00 - 19:00 | Post-Congress Symposium: The Basics I – Expert Approaches |
| 500.2 |
My approach to CMV in organ transplantation Raymund Razonable, United States |
| 500.1 |
My approach to BKV in renal transplantation Joanna Schaenman, United States |
| 500.3 |
My approach to HCV in organ transplantation Nassim Kamar, France |
| 500.4 |
My approach to HBV in organ transplantation Wan Cheng Chow, Singapore |
| 18:00 - 19:00 | Post-Congress Symposium: The Basics II – Pre-Transplant Problems |
| 505.3 |
The lung transplant patient with NTM Shahid Husain, Canada |
| 505.4 |
Excluding Covid-19 in deceased donors – the role of serology and PCR Wanessa Trindade Clemente, Brazil |
| 505.1 |
Preparing the patient for an intestinal transplant – the ID perspective Fernanda Silveira, United States |
| 18:00 - 19:00 | Post-Congress Symposium: Some Specifics I – Testing, Testing |
| 510.4 |
Next generation sequencing – how will it benefit the transplant recipient William David Rawlinson, Australia |
| 510.3 |
Urinalysis and urine cultures in kidney recipient follow-up – right or wrong Kyong-Ran Peck, Korea |
| 510.2 |
Meningitis and GI panels – boon or bane to TID? Siriorn Watcharananan, Thailand |
| 510.1 |
Treating all that’s + in BAL in lung transplant – right or wrong Robin Avery, United States |
| 18:00 - 19:00 | Post-Congress Symposium: Some Specifics II – Less common, but not less important |
| 515.2 |
Treating TB post-transplant Guilherme Santoro Lopes, Brazil |
| 515.4 |
Cryptococcus – from pre- to post-transplant management Hsin-Yun Sun, Taiwan |
| 515.1 |
PCP prophylaxis - the small print Jay A. Fishman, United States |
| 515.3 |
Strongyloides – the forgotten worm Michele Ilene Morris, United States |
| Poster Session: Infectious Disease |
| P-9.01 |
Vaccine-preventable infections among solid organ transplant recipients: a data-linked cohort study, Australia, 2000-2015 Karen Waller, Australia |
| P-9.03 |
Aspergillosis complicating severe Influenza and RSV pneumonia in ICU patients: A retrospective cohort study Hannah H Nam, United States |
| P-9.05 |
The level of plasm donor-derived cell-free DNA in kidney transplant patients with severe pneumonia Liu Feng, People's Republic of China |
| P-9.07 |
Acquisition and kinetics of EBV infection amongst pediatric liver transplant recipients in Japan Masaki Yamada, Japan |
| P-9.08 |
New blood borne virus infections among organ transplant recipients: a data-linked cohort study examining transmitted and de novo hepatitis B, C and HIV infections Karen Waller, Australia |
| P-9.10 |
Ten year challenge: How the etiology and resistance patterns of blood stream ınfections in solid organ transplantation recipients have changed? Cigdem Erol, Turkey |
| P-9.11 |
Impact of Cytomegalovirus (CMV) infection in post renal transplant: A single center experience Rutul Manojkumar Dave, India |
| P-9.15 |
BK virus allograft nephropaty in renal transplant recipients Nasly G Patino-Jaramillo MD, Colombia |
| P-9.17 |
Lymphocytopenia and neutrophilia determined fungal infection occurrence and mortality after liver transplantation Jiang Liu, People's Republic of China |
| P-9.19 |
Epidemiology of Nocardia spp infections in heart transplant recipients at a single center Hannah H Nam, United States |
| P-9.20 |
Clinical characteristics and outcome of herpes zoster in solid organ transplant patients: A single center case series Cemile Tugba Altunel, Turkey |
| P-9.21 |
Residual foreign body and frequency of infection after heart transplantation Michiru Nomoto, Japan |
| P-9.22 |
Last two influenza season: Evaluation of solid organ transplant recipients Hande Arslan, Turkey |
| P-9.23 |
Clinical characteristics and long-term outcomes of cryptococcosis in solid organ transplant recipients Pakpoom Phoompoung, Thailand |
| P-9.24 |
Herpes simplex virus type 1 encephalitis in kidney transplant patient: A case report Nasly G Patino-Jaramillo MD, Colombia |
| P-9.27 |
Variation of BKV DNA quantitation in neat and stabilized urine due to target inhomogeneity Akos Somoskovi, United States |
